Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

ARNA 1.67 +0.01 (0.60%)
price chart
Analyst's PT Viewpoints: Eli Lilly and Company (NYSE:LLY) , Arena ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed with decline of -1.19% to $1.66. Recent traded volume was 719.69 thousand shares versus to it an average volume of 1.82 million shares.
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharmaceuticals Inc. ARNA, -5.62% shares rose 8.8% in pre-market trade Tuesday after the company said its weight-loss drug with Eisai Inc. 4523, +0.46% received Food and Drug Administration approval.
Arena Pharmaceuticals Inc Stock Technicals at Critical Inflection Point
This is a technical analysis stock rating for Arena Pharmaceuticals Inc (NASDAQ:ARNA) . The company has a three bull technical rating which indicates an inflection point.
Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 19, 2016 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S.
Arena - Belviq Scripts Start Q3 In Tough Shape  Seeking Alpha
Latest Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Target Price Suggests Stock ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) up 1.2 per cent in the past week, is under coverage of 7 analysts who collectively recommend a hold rating on stock.
Two Stocks within Analysts Review: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...  Street Updates
Trading the Biotech News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Biogen ...  The Voice Registrar
Which way Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) insiders are heading
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) up 11.25 per cent in the past week, is under coverage of 7 analysts who collectively recommend a hold rating on stock.
Broker Outlook For Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Fiscal Standard
Company Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. and Eisai Inc ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc. announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has granted regulatory approval of the chronic weight management agent VENESPRI´┐Ż(lorcaserin HCl: ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Receives Consensus Rating of " ...  BBNS
Arena Pharmaceuticals boosted as obesity drug gets Mexican approval  Proactive Investors USA & Canada
Biotech Stocks Worth Chasing: Arena Pharmaceuticals, Inc. (ARNA), ZIOPHARM ...
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of 2.41 percent. It trades at an average volume of 1.75M shares versus 1.84M shares recorded at the end of last trading session.
Arena Pharmaceuticals Inc. (ARNA) Shares Bought by Wellington Management Group LLP
Arena Pharmaceuticals logo Wellington Management Group LLP raised its position in shares of Arena Pharmaceuticals Inc. (NASDAQ:ARNA) by 7.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange ...
How Analysts Feel About Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)?  Press Telegraph
Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Sellers Covered 5.74% of ...  Consumer Eagle
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Broker Price Targets For The Coming Week
05/13/2015 - Arena Pharmaceuticals, Inc. had its “market perform” rating reiterated by analysts at BMO Capital Markets.